Toral Mehta

Dr. Toral Mehta

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
BSBalaji Sadhasivam
Balaji Sadhasivam
JMJimmy Manyanga
Jimmy Manyanga
VGVengatesh Ganapathy
Vengatesh Ganapathy
PAPawan Acharya
Pawan Acharya
CBCélia Bouharati
Célia Bouharati
Lurdes QueimadoLurdes Queimado
Lurdes Queimado
Chemotherapy and radiotherapy resistance are major obstacles in the long-term efficacy of head and neck squamous cell carcinoma (HNSCC) treatment. Secondhand smoke (SHS) exposure is common and has been proposed as an independent predictor of HNSCC recurrence and disease-free survival. However, the underlying mechanisms responsible for these negative patient outcomes are unknown. To assess the effects of SHS exposure on cisplatin efficacy in cancer cells, three distinct HNSCC cell lines were exposed to sidestream (SS) smoke, the main component of SHS, at concentrations mimicking the nicotine level seen in passive smokers’ saliva and treated with cisplatin (0.01–100 µM) for 48 h. Compared to cisplatin treatment alone, cancer cells exposed to both cisplatin and SS smoke extract showed significantly lower cisplatin-induced cell death and higher cell viability, IC50, and indefinite survival capacity. However, SS smoke extract exposure alone did not change cancer cell viability, cell death, or cell proliferation compared to unexposed control cancer cells. Mechanistically, exposure to SS smoke extract significantly reduced the expression of cisplatin influx transporter CTR1, and increased the expression of multidrug-resistant proteins ABCG2 and ATP7A. Our study is the first to document that exposure to SHS can increase cisplatin resistance by altering the expression of several proteins involved in multidrug resistance, thus increasing the cells’ capability to evade cisplatin-induced cell death. These findings emphasize the urgent need for clinicians to consider the potential role of SHS on treatment outcomes and to advise cancer patients and caregivers on the potential benefits of avoiding SHS exposure.

21 October 2025 in Addictive Behaviors
Verified
Journal Article
Open access
MBMarielle C. Brinkman
Marielle C. Brinkman
TMToral Mehta
Toral Mehta
MPMichael L. Pennell
Michael L. Pennell
DADavid Angeles
David Angeles
SKSoliana Kahassai
Soliana Kahassai
AFAmy K. Ferketich
Amy K. Ferketich
Waterpipe (WP) smoking is commonly misperceived as less harmful than cigarette smoking. Graphic warning labels (GWLs) may correct misperceptions and reduce WP smoking. We determined the impact of a GWL placed on a WP on short-term smoking behaviors and other outcomes among young adults who smoke WP. Young adults, ages 21-35 years, who smoke WP were randomized to a control (Visit1 = Blank, Visit2 = Blank label) or experimental (Visit1 = Blank, Visit2 = GWL, Visit3 = GWL) group. Participants smoked a research-grade WP in the lab ad lib to satiation, for a maximum of 60 min, for up to 3 visits, each separated by a week. Puffing topography was measured continuously throughout the session. Exhaled CO, harm perceptions, and subjective effects were measured before and after each smoking session. Outcome data were analyzed using linear mixed models to account for incomplete, repeated measurements. There were no significant differences in study outcomes within and between assigned groups, except for the following from Visit1 and Visit3 in the GWL group: 1) a reduction in puff volume (p = 0.048); 2) a reduction in good taste and calmness (p = 0.027 and 0.007, respectively); and 3) a reduction in being confused after smoking (p = 0.042). GWLs on WPs may not be the sole effective tool for reducing the harm from WP smoking. More research is needed to determine if WP interventions aimed at improving population health should include a wider variety of tools, such as education, cessation services, and product standards that limit the appealing aspects of WP tobacco.

23 October 2026 in Addiction
Verified
Journal Article
Open access
YCYoojin Cho
Yoojin Cho
AHAlice Hinton
Alice Hinton
JNJean Nshimiyimana
Jean Nshimiyimana
TMToral Mehta
Toral Mehta
ABAlexis Bobu
Alexis Bobu
Theodore WagenerTheodore Wagener
Theodore Wagener
Aims: To characterize changes in preferred e‐cigarette (EC) flavor, nicotine concentration, wattage and air valve openness over 12 weeks among adults who smoke and are attempting to switch to ECs, and examine whether these changes are associated with cigarettes smoked per day (CPD). Design: Secondary analysis of two arms of a three‐arm randomized controlled trial (NCT03113136). Setting: Two Midwestern United States cities. Participants: 265 adults uninterested in quitting smoking (38% male, 62% female, mean age 40.0 years, 83% white, mean 17 CPD), randomized to lower‐wattage EC ( n = 132) or higher‐wattage EC ( n = 133). Measurements: Preferred EC flavor (tobacco/tobacco blend, menthol, fruit/sweet), nicotine concentration, wattage, air valve openness (higher‐wattage EC only) and CPD were assessed at baseline, 1‐week, 4‐week, 8‐week and 12‐week follow‐ups. Results: Over 12 weeks, mean CPD decreased by approximately 10 cigarettes, from 16.7 to 6.6 in the lower‐wattage group and from 17.4 to 7.0 in the higher‐wattage group. Most participants preferred fruit/sweet flavors (58.2% at week 12). Throughout the study, participants preferred nicotine concentrations of 12 mg/ml in the lower‐wattage group and 6 mg/ml in the higher‐wattage group. Preferred nicotine concentrations generally decreased from baseline to week 12 for both groups, though the decrease was statistically significant only in the lower‐wattage group. In the higher‐wattage group, preferred wattage and air valve openness generally increased from baseline to week 12, with a statistically significant increase observed only for wattage from baseline to week 8 (23.22 W to 27.07 W). In the lower‐wattage group, preferred EC settings were not associated with CPD at follow‐ups. In the higher‐wattage group, menthol flavor preference (vs. tobacco) and higher nicotine concentrations were associated with CPD reductions at follow‐ups. Summary: Among adults who smoke cigarettes and are switching to e‐cigarettes, preferences for e‐cigarette settings (flavor, nicotine concentration, wattage and air valve openness) did not change substantially over the first 12 weeks of use. Flavors and nicotine concentration options may support smoking reduction in adults who transition to e‐cigarettes.